These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19812413)

  • 1. Thrombomodulin in atypical hemolytic-uremic syndrome.
    Edey MM
    N Engl J Med; 2009 Oct; 361(15):1511; author reply 1511. PubMed ID: 19812413
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
    Delvaeye M; Noris M; De Vriese A; Esmon CT; Esmon NL; Ferrell G; Del-Favero J; Plaisance S; Claes B; Lambrechts D; Zoja C; Remuzzi G; Conway EM
    N Engl J Med; 2009 Jul; 361(4):345-57. PubMed ID: 19625716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.
    Boels MG; Lee DH; van den Berg BM; Dane MJ; van der Vlag J; Rabelink TJ
    Eur J Intern Med; 2013 Sep; 24(6):503-9. PubMed ID: 23357408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of hemolytic uremic syndrome after renal transplantation.
    Seitz B; Albano L; Vocila F; Mzoughi S; Aoudia R; Guitard J; Ribes D; Vachet-Copponat H; Mourad G; Bienaimé F; Dahan P; Frémeaux-Bacchi V; Cassuto E
    Transplant Proc; 2007 Oct; 39(8):2583-5. PubMed ID: 17954182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane cofactor protein and factor I: mutations and transplantation.
    Kavanagh D; Goodship TH
    Semin Thromb Hemost; 2006 Mar; 32(2):155-9. PubMed ID: 16575690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?
    Noris M; Remuzzi G
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):2-3. PubMed ID: 16932353
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

  • 11. [The genetic background of haemolytic-uraemic syndrome].
    Zurowska A
    Przegl Lek; 2006; 63 Suppl 3():15-6. PubMed ID: 16898478
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of disinhibition of complement activation.
    Eisenhut M
    Pediatr Crit Care Med; 2010 Sep; 11(5):631-2. PubMed ID: 20823737
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin.
    Watt T; Warshaw B; Katzenstein HM
    Pediatr Blood Cancer; 2009 Jul; 53(1):90-1. PubMed ID: 19301397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation in the hemolytic-uremic syndrome.
    DiBartolomeo A; Parker DL
    Urology; 1975 Jul; 6(1):71-3. PubMed ID: 1096403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of atypical hemolytic uremic syndrome is not influenced by thrombophilia susceptibility factors.
    Kemp EJ; Strain L; Diaz-Torres ML; Goodship JA; Goodship TH
    J Thromb Haemost; 2005 Sep; 3(9):2128-30. PubMed ID: 16102133
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in understanding of pathogenesis of aHUS and HELLP.
    Fang CJ; Richards A; Liszewski MK; Kavanagh D; Atkinson JP
    Br J Haematol; 2008 Nov; 143(3):336-48. PubMed ID: 18691170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome in siblings.
    Kaplan BS
    Clin Nephrol; 1985 Jan; 23(1):51. PubMed ID: 3978882
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial hemolytic uremic syndrome: a privileged observation.
    Pirson Y; Lefebvre C; Lambert C; Warwicker P; Goodship T
    Bull Mem Acad R Med Belg; 2004; 159(Pt 2):191-4. PubMed ID: 15615092
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent glomerular disease in transplants.
    Furness PN; Roberts IS; Briggs JD
    Transplant Proc; 2002 Sep; 34(6):2422. PubMed ID: 12270464
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
    Ståhl AL; Kristoffersson A; Olin AI; Olsson ML; Roodhooft AM; Proesmans W; Karpman D
    Mol Immunol; 2009 Jul; 46(11-12):2236-43. PubMed ID: 19446882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.